GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
The Silicon Review

Zepbound vs Wegovy: One Hormone or Two, Here's What Changes

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...
Scientific American

The next wave of GLP-1 drugs are coming—and they’re stronger than Wegovy and Zepbound

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much ...
Fierce Biotech

Novo's CagriSema loses phase 3 battle with Lilly's Zepbound, knocking 15% off share price

Novo Nordisk’s GLP-1/amylin combo has failed to beat Eli Lil | Novo Nordisk’s GLP-1/amylin combo has failed to beat Eli Lilly ...
Hosted on MSN

Zepbound vs. Wegovy: Which is better for weight loss?

Zepbound may lead to more weight loss than Wegovy, with participants losing 20.2% of their body weight in a clinical trial. Participants on Zepbound had a greater decrease in waist size, losing ...
Benzinga.com

After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

Novo Nordisk’s Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity

Awareness and prescribing of the Wegovy pill for weight loss surge among primary care physicians and endocrinologists following its January launch.Exton, PA, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The ...

Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’

Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations ...